One of my long-shot, single-product, home-run-hopeful stocks presented their product at a conference today and indicated that it has some new benefits which had not been seen before. It may end up being useful in the treatment of diabetes!

Quoted: New Study Explores Use of Novel Form of Northfield's Human Hemoglobin-Based Oxygen Carrier in Pancreatic Islet Cell Transplantation. - EVANSTON, Ill.--(BUSINESS WIRE)--July 27, 2006--Northfield Laboratories Inc. (Nasdaq: NFLD - News) announced today that a preclinical study describing the use of a novel formulation of the Company's human hemoglobin-based oxygen carrier in pancreatic islet cell isolation and transplantation was presented at the World Transplantation Congress in Boston this morning.